Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Rossi, Ernesto, Schinzari, Giovanni, Zizzari, Ilaria Grazia, Maiorano, Brigida Anna, Pagliara, Monica Maria, Sammarco, Maria Grazia, Fiorentino, Vincenzo, Petrone, Gianluigi, Cassano, Alessandra, Rindi, Guido, Bria, Emilio, Blasi, Maria Antonietta, Nuti, Marianna, Tortora, Giampaolo
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2019
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721347/
https://ncbi.nlm.nih.gov/pubmed/31357439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081055
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge